Beta
387980

Safety and efficacy of different doses of intrathecal magnesium sulfate on the acute and chronic postoperative pain in patient undergoing pelvic cancer surgeries - a randomized c

Article

Last updated: 05 Jan 2025

Subjects

-

Tags

-

Abstract

Background and objectives
Excision of tumors from pelvis causing severe pain postoperatively. Hemodynamic stability, and better analgesia were documented when MgSO4 was used as an adjuvant to local anesthesia. We aimed to investigate the effect of using intrathecal MgSO4 with different doses as an adjuvant to LAs on postoperative acute pain, hemodynamics, and chronic pain.
Methods
Ninety patients scheduled for pelvic surgery for excision of tumors have been included in this study and divided into three groups; all patient received general anesthesia (GA) plus intrathecal fentanyl (group A), while the second (group B) and the third (group C) received intrathecal magnesium sulfate 50 mg and 100 mg, respectively; intra- and postoperative outcomes such as hemodynamics, (LANSS) pain score, (NRS) and postoperative complications have been measured.
Results
The results revealed that MgSO4 in the (group B) had significant effect on decreasing the postoperative pain during the first 24 hours; the result of the three groups revealed that there was statistically significant difference between the group A and groups (B-C) (P-value >0.05), while there was insignificant statistical difference between the group B and group C. Patients in the fentanyl group requested analgesic after 6 to 8 hours (mean ±SD 8.4817 ± 0.819 mg), while patients in group B after 12 to 14 hours postoperatively (13.7450 ± 0.86477 mg) and patients in group C requested analgesia 16 hours postoperatively (13.7800 ± 1.00272 mg). LANSS score was significantly improved in groups B-C, but fewer complications such as itching, nausea and shorter time of recovery after the surgery in group B than other groups.
Conclusion
When comparing IT magnesium sulfate at doses of 50 and 100 to fentanyl 50 mg, we found superiority of MgSO4, in decreasing pain after surgery and ITMgSO4 50 mg achieved a reasonable balance between postoperative analgesia and side effects. In addition, ITMgSO4 has shown significant effect in decreasing the chronic pain postoperatively.

DOI

TEJA-2023-0152

Keywords

magnesium sulfate, Chronic pain, pelvic cancer surgeries, NRS, LANSS score

Authors

First Name

Alaa Ali M.

Last Name

Elzohry

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Tarek Abdelazeem

Last Name

Sabra

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Mohammed Moustafa

Last Name

Hussein

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Fatma Al Zahraa Hamed

Last Name

Abdel Hameed

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Mohamad Farouk.

Last Name

Mohamad

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

39

Article Issue

1

Related Issue

51163

Issue Date

2023-12-01

Receive Date

2023-07-01

Publish Date

2023-12-31

Page Start

828

Page End

839

Print ISSN

1110-1849

Online ISSN

1687-1804

Link

https://egja.journals.ekb.eg/article_387980.html

Detail API

https://egja.journals.ekb.eg/service?article_code=387980

Order

387,980

Publication Type

Journal

Publication Title

Egyptian Journal of Anaesthesia

Publication Link

https://egja.journals.ekb.eg/

MainTitle

Safety and efficacy of different doses of intrathecal magnesium sulfate on the acute and chronic postoperative pain in patient undergoing pelvic cancer surgeries - a randomized c

Details

Type

Article

Created At

21 Dec 2024